发明名称 New mRNA indicative of T cell activation and functional status, useful for diagnosis and therapy e.g. of autoimmunity or transplant rejection
摘要 Messenger RNA, (mRNA), (I), for use as indicator of the activation and functional status of T cells, that have increased or reduced expression, and are present at higher or lower concentration, in activated T cells, relative to normal or resting cells, where (I) hybridizes to any of 334 sequences, reproduced, or their derivatives, complements or fragments, is new. Independent claims are also included for the following: (a) polynucleotides (II) with any of the 334 specified sequences (or their derivatives, complements or fragments that hybridize to them) for use as reagent for determining the activation or functional status of T cells; (b) polypeptides (III) derived from (II); (c) reagent for determining the activation or functional status of T cells comprising (II); (d) recombinant DNA vector molecules (IV) containing one or more (II) and transcribable in T cells; (e) antibody (Ab) specific for (III); and (f) binding molecules (IV) that react specifically with (II).
申请公布号 DE10021834(A1) 申请公布日期 2001.11.15
申请号 DE2000121834 申请日期 2000.05.06
申请人 LYNX THERAPEUTICS GMBH 发明人 KRAMER, MICHAEL DIETER;WINTER, HOLGER;REINARTZ, JEANETTE
分类号 C07K14/47;C12N15/10;C12Q1/68 主分类号 C07K14/47
代理机构 代理人
主权项
地址